Health condition
Anorgasmia, delayed or absent orgasm, gently explained and properly treated.
A common, treatable concern that often has a clear cause. This guide covers medication effects, menopause, psychological and relational factors, and what modern UK care looks like.
Why trust this guide
- 01
Editorial team
Written by our editorial team from the UK sources listed on each page.
- 02
Sourced from guidance
Checked against BASHH, BSSM, NICE and peer-reviewed sexual medicine sources you can see at the end.
- 03
Current for 2026
Reflects modern UK psychosexual medicine practice, HRT for menopause, and post-SSRI sexual dysfunction awareness.
Key facts
Anorgasmia at a glance.
The essentials, in plain English. Common, often driven by treatable causes, and worth talking about openly with someone trained to listen.
-
What it is
Persistent delay in, or absence of, orgasm after adequate sexual stimulation and arousal that causes personal distress.
-
Lifelong vs acquired
Lifelong means never experienced orgasm; acquired means loss of a previously present response. Cause and treatment differ.
-
Generalised vs situational
Generalised (any context) often points to medication or physiology; situational (with a partner but not solo) often points to relational or psychological factors.
-
How common
Primary anorgasmia affects roughly 5 to 10 per cent of women; acquired forms are more common with age, menopause and antidepressant use.
-
Biggest driver
SSRIs and SNRIs, with 60 to 70 per cent of patients reporting sexual side effects including delayed or absent orgasm.
-
Foundation of care
A sensitive history, medication review, targeted bloods and, when needed, psychosexual therapy alongside biological treatment.
Why this guide matters
One question, three routes to the answer.
Most anorgasmia falls into one of three families - medication, hormones and body, or mind and relationship. Naming the pattern is half the treatment.
-
Medication is the first place to look
SSRIs, SNRIs, antipsychotics, opiates and some blood pressure medicines are frequent culprits. A prescriber-led review often changes the picture.
-
Hormones and body come next
Menopause, thyroid disease, raised prolactin, diabetes and neurological conditions can all affect orgasmic response. Bloods and history matter here.
-
Mind and relationship matter too
Anxiety, trauma, low mood, cultural inhibition and relational strain are treatable in their own right, usually with psychosexual therapy.
How the assessment is made
A careful conversation, then a considered plan.
The steps a UK GP or psychosexual specialist will normally follow, in order, and always at the pace that feels right for you.
Phase 1 · Understanding
History, questionnaires and medication review
Phase 2 · Investigating
Bloods, mental health and context
Phase 3 · Referring
Specialist psychosexual medicine
- 01
Understanding
A sensitive sexual history
Taken privately and without judgement. Onset (lifelong or acquired), context (generalised or situational), arousal, desire, pain and relationship factors.
- 02
Understanding
Validated questionnaires
FSFI and FSDS for women, CSFQ for either sex. They put a shared number on distress and help track change over time.
- 03
Understanding
Medication and substance review
A close look at SSRIs, SNRIs, antipsychotics, mood stabilisers, opiates, beta-blockers, diuretics, hormonal contraception, alcohol, cannabis and cocaine.
- 04
Investigating
Hormone and thyroid bloods
TSH, prolactin, total testosterone with SHBG, oestradiol, LH and FSH where indicated. Menopause status where relevant.
- 05
Investigating
Mental health and trauma screen
Depression, anxiety, PTSD, previous sexual trauma or abuse. Asked gently and only as far as you want to go on the day.
- 06
Investigating
Relationship and context review
Communication, safety, cultural or religious factors, body image, stimulation and technique. Situational patterns matter here.
- 07
Referring
Psychosexual medicine referral
For complex, distressing or treatment-resistant presentations, a specialist psychosexual clinician can coordinate the plan.
Typical timeline: a first conversation to a working plan across one or two appointments.
What it can look like
The patterns clinicians recognise.
Anorgasmia is not one experience. These are the shapes it commonly takes, and the features that help point to the right treatment.
-
Delayed orgasm
Orgasm eventually occurs but requires much longer stimulation than you or your partner would expect.
-
Absent orgasm
No orgasm despite adequate arousal and stimulation, in some or all contexts.
-
Reduced intensity
Orgasms feel muted, blunted or emotionally flat compared with previous experience.
-
Situational pattern
Orgasm possible alone but not with a partner (or vice versa). Suggests relational or contextual drivers.
-
Generalised pattern
No orgasm in any setting. More often points to medication, hormonal or neurological factors.
-
Reduced desire or arousal
Often present alongside anorgasmia and worth treating in its own right.
-
Emotional distress
Frustration, shame, low mood or relationship strain. Distress is what turns a variation into a treatable concern.
-
Red flag - new neurological symptoms
New numbness, weakness, bladder or bowel change alongside anorgasmia needs prompt neurological review.
Treatment
How anorgasmia is treated in the UK.
Treat the underlying cause first, review medications carefully, and add psychosexual therapy and (where useful) devices, HRT or testosterone.
-
Treat the underlying cause
Optimise HRT for menopause, address thyroid or prolactin abnormality, manage diabetes or depression. Often the single biggest lever.
-
Review the medication list
Consider switching an SSRI to bupropion, mirtazapine or vortioxetine, which are less associated with sexual side effects. Never stop antidepressants abruptly.
-
Add-on bupropion
Sometimes added to an SSRI to counteract sexual side effects. A specialist decision, not a self-adjustment.
-
Psychosexual therapy
Sensate focus, CBT, mindfulness and, where relevant, couple therapy. The best-evidenced treatment for situational and psychological forms.
-
Devices and stimulation aids
Clitoral suction devices, high-quality vibrators and pelvic-floor biofeedback can help unlock or retrain the orgasmic response.
-
Pelvic floor physiotherapy
For overactive or underactive pelvic floor patterns contributing to reduced sensation or pain-related inhibition.
-
Testosterone for women
For post-menopausal HSDD contributing to anorgasmia, prescribed off-label under specialist supervision with monitoring.
-
Trauma-focused therapy
Where PTSD or a history of sexual abuse is present, trauma-focused CBT or EMDR is often the priority before further sexual interventions.
What this guide is based on
The sources behind every claim on this page.
UK sexual medicine guidance and international consensus standards, current at the time of last review.
Key references
Guidelines and standards we relied on.
A quiet reminder
This guide is for information, not personal medical advice.
Your GP or a psychosexual specialist knows your history and can tell you which parts of this apply to you. If it is affecting your wellbeing, please do speak to someone.
-
British Society for Sexual Medicine (BSSM). Guidelines on female and male sexual dysfunction.
-
NICE. Menopause: diagnosis and management (NG23) and depression guidance (NG222).
-
Institute of Psychosexual Medicine (IPM). Standards for psychosexual assessment and therapy.
-
International Society for the Study of Women’s Sexual Health (ISSWSH). Consensus statements on female orgasmic disorder.
Red flags
When to seek urgent or specialist help.
Most anorgasmia is manageable in primary care with a good history and medication review. These are the situations that need a different pathway.
-
New neurological symptoms
Numbness, weakness, saddle anaesthesia or bladder/bowel change alongside anorgasmia needs urgent neurological assessment.
-
Suspected spinal cord pathology
Sudden loss of orgasmic response with back pain or leg symptoms should be reviewed the same day.
-
Disclosure of sexual trauma or abuse
Handled with care, safety-first, and a warm referral to trauma-informed psychological support.
-
Severe depression or suicidality
Sexual dysfunction can worsen mood; low mood or suicidal thoughts need urgent GP or crisis support before further sexual treatment.
-
Post-SSRI sexual dysfunction (PSSD)
Persistent sexual side effects continuing after antidepressant discontinuation deserves specialist recognition and a considered plan.
-
Post-orgasmic illness syndrome (POIS)
A rare pattern of flu-like symptoms after orgasm; needs specialist assessment rather than self-management.
-
Unexplained hyperprolactinaemia
Requires pituitary evaluation, medication review and endocrine input before treating the sexual symptom alone.
-
Rapid onset with new medication
A clear temporal link to a newly started medication should prompt a prescriber-led review, not silent adjustment.
-
Bleeding, pain or lump
Any coexisting gynaecological or urological red flag takes precedence and needs its own pathway.
Living with it
A treatable concern, held gently.
Four things that make the biggest difference day to day. None of them require perfect knowledge, only a willingness to begin the conversation.
A quiet reminder
Nothing about this makes you broken.
Anorgasmia is common, understandable and usually treatable. The clinicians who work in this field will not be surprised, or embarrassed, by anything you bring.
- 01 Language
Name it kindly
Anorgasmia is a common, treatable clinical concern. Naming it takes it out of the shadows and into a plan.
- 02 Context
Notice the pattern
Lifelong or acquired, generalised or situational. That single sentence often points to where the answer sits.
- 03 Patience
Give changes 8 to 12 weeks
Medication swaps, HRT and psychosexual therapy all take time. Judge progress in months, not days.
- 04 Together
Consider a shared conversation
Where a partner is involved, couple-based work often unlocks more than individual therapy alone.
Frequently asked
The questions we hear most.
Honest, non-judgemental answers on medication effects, menopause, therapy and what to expect from a first appointment.
-
What is anorgasmia?
Anorgasmia is a persistent delay in, or absence of, orgasm after what would normally be adequate arousal and stimulation, causing personal distress. It can be lifelong or acquired, and generalised across all contexts or situational to specific settings.
-
Is it common?
Yes. Primary (lifelong) anorgasmia affects roughly 5 to 10 per cent of women, and acquired forms are more common with menopause and antidepressant use. It also occurs in men, though less commonly, and is often under-reported for both sexes.
-
Could my antidepressant be the cause?
Very possibly. SSRIs and SNRIs are the single most common medication cause, with 60 to 70 per cent of patients reporting sexual side effects including delayed or absent orgasm. Never stop your antidepressant on your own - talk to your prescriber about switching to bupropion, mirtazapine or vortioxetine, which are less likely to cause this.
-
How does menopause fit in?
Falling oestrogen and, for many women, falling testosterone can reduce arousal, sensation and orgasmic response. Optimising HRT (often including vaginal oestrogen for genitourinary syndrome of menopause) and, in some cases, adding testosterone under specialist care can help significantly.
-
What does psychosexual therapy involve?
A structured, confidential course of sessions using approaches like sensate focus, CBT and mindfulness, sometimes with a partner. It is not "just talking" - it is a practical, evidence-based treatment for situational and psychological forms of anorgasmia.
-
Are devices like vibrators actually recommended?
Yes. Clitoral suction devices and high-quality vibrators are legitimate clinical tools, often recommended by psychosexual clinicians alongside therapy. For many women they are the fastest route to re-establishing or discovering the orgasmic response.
Related content
Keep reading.
-
Depression
Mood and antidepressants both affect orgasm.
Learn more -
Anxiety
A common driver of situational anorgasmia.
Learn more -
Menopause
Oestrogen and testosterone change the picture.
Learn more -
PCOS
Endocrine driver worth screening for.
Learn more -
Testosterone for women
For post-menopausal HSDD contributing to symptoms.
Learn more -
Menopause blood panel
Hormones, thyroid and prolactin in one visit.
Learn more -
BHRT (bioidentical hormones)
Body-identical HRT tailored to your profile.
Learn more -
PCOS clinic
Specialist review for hormonal drivers.
Learn more -
Endometriosis clinic
Pain-related inhibition of arousal and orgasm.
Learn more -
Private psychiatric assessment
Where mood, trauma or PTSD is a driver.
Learn more -
Couples therapy
Where the relationship is part of the picture.
Learn more -
DBT (dialectical behaviour therapy)
For emotional regulation and trauma-linked patterns.
Learn more -
Fertility MOT with AMH
Wider hormonal picture for women planning ahead.
Learn more -
All conditions
Browse every clinical guide.
Learn more